These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 19284182

  • 1. Metabolic cardiology: the missing link in cardiovascular disease.
    Sinatra ST.
    Altern Ther Health Med; 2009; 15(2):48-50. PubMed ID: 19284182
    [Abstract] [Full Text] [Related]

  • 2. Metabolic cardiology: an integrative strategy in the treatment of congestive heart failure.
    Sinatra ST.
    Altern Ther Health Med; 2009; 15(3):44-52. PubMed ID: 19472864
    [Abstract] [Full Text] [Related]

  • 3. [Physiological aspects of ubiquinone supplementation in cardiovascular pathology].
    Kuchmenko OB.
    Fiziol Zh (1994); 2006; 52(5):80-91. PubMed ID: 17176844
    [Abstract] [Full Text] [Related]

  • 4. Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: metabolic inhibitors, MPTP, and methamphetamine.
    Virmani A, Gaetani F, Binienda Z.
    Ann N Y Acad Sci; 2005 Aug; 1053():183-91. PubMed ID: 16179522
    [Abstract] [Full Text] [Related]

  • 5. Heart metabolic disturbances in cardiovascular diseases.
    Carvajal K, Moreno-Sánchez R.
    Arch Med Res; 2003 Aug; 34(2):89-99. PubMed ID: 12700003
    [Abstract] [Full Text] [Related]

  • 6. Modification of myocardial substrate utilisation: a new therapeutic paradigm in cardiovascular disease.
    Beadle RM, Frenneaux M.
    Heart; 2010 Jun; 96(11):824-30. PubMed ID: 20478861
    [Abstract] [Full Text] [Related]

  • 7. [Cellular energy metabolism: physiologic and pathologic aspects].
    Sztark F, Payen JF, Piriou V, Rigoulet M, Ventura-Clapier R, Mazat JP, Leverve X, Janvier G.
    Ann Fr Anesth Reanim; 1999 Feb; 18(2):261-9. PubMed ID: 10207603
    [Abstract] [Full Text] [Related]

  • 8. Biochemical factors limiting myocardial energy in a chicken genotype selected for rapid growth.
    Nain S, Ling B, Alcorn J, Wojnarowicz CM, Laarveld B, Olkowski AA.
    Comp Biochem Physiol A Mol Integr Physiol; 2008 Jan; 149(1):36-43. PubMed ID: 17988909
    [Abstract] [Full Text] [Related]

  • 9. D-ribose, a metabolic substrate for congestive heart failure.
    Wagner S, Herrick J, Shecterle LM, St Cyr JA.
    Prog Cardiovasc Nurs; 2009 Jun; 24(2):59-60. PubMed ID: 19523159
    [Abstract] [Full Text] [Related]

  • 10. Coenzyme Q in cardiovascular disease.
    Singh RB, Niaz MA, Rastogi V, Rastogi SS.
    J Assoc Physicians India; 1998 Mar; 46(3):299-306. PubMed ID: 11273351
    [Abstract] [Full Text] [Related]

  • 11. Ribose in the heart.
    Herrick J, St Cyr J.
    J Diet Suppl; 2008 Mar; 5(2):213-7. PubMed ID: 22432434
    [Abstract] [Full Text] [Related]

  • 12. Coenzyme Q10 in cardiovascular disease.
    Pepe S, Marasco SF, Haas SJ, Sheeran FL, Krum H, Rosenfeldt FL.
    Mitochondrion; 2007 Jun; 7 Suppl():S154-67. PubMed ID: 17485243
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A sugar that benefits failing hearts.
    St Cyr JA, Schneider JR.
    Int J Cardiol; 2009 Jan 24; 131(3):398. PubMed ID: 17996314
    [Abstract] [Full Text] [Related]

  • 16. Carnitine and coenzyme Q10: biochemical properties and functions, synergism and complementary action.
    Bertelli A, Ronca G.
    Int J Tissue React; 1990 Jan 24; 12(3):183-6. PubMed ID: 2276898
    [Abstract] [Full Text] [Related]

  • 17. The heart requires glycerol as an energy substrate through aquaporin 7, a glycerol facilitator.
    Hibuse T, Maeda N, Nakatsuji H, Tochino Y, Fujita K, Kihara S, Funahashi T, Shimomura I.
    Cardiovasc Res; 2009 Jul 01; 83(1):34-41. PubMed ID: 19297367
    [Abstract] [Full Text] [Related]

  • 18. [Energy metabolism in the failing heart].
    Chodorowski Z, Rybakowska I, Anand JS, Kaletha K.
    Przegl Lek; 2009 Jul 01; 66(6):356-8. PubMed ID: 19788151
    [Abstract] [Full Text] [Related]

  • 19. Metabolic therapy for the treatment of ischemic heart disease: reality and expectations.
    Wang W, Lopaschuk GD.
    Expert Rev Cardiovasc Ther; 2007 Nov 01; 5(6):1123-34. PubMed ID: 18035928
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.